• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Achieving Commercial Success Through the National Institutes of Health's Intramural Research Program

Wednesday, June 05, 2024
Breakout Session
Business Development and Finance
32AB
Since the 1970s, the Intramural Research Program (IRP) has served as the in-house research and clinical arm of the NIH. Despite their success, many potential industry collaborators and licensees still see NIH solely as a basic research center funding academic research and publishing academic papers. This session will provide case studies of what kinds of support — including indirect funding, core facilities, manufacturing, and regulatory assistance — helps companies cross the valley of death and build shareholder value. Company representatives will provide best practices and personal stories of how they worked with the NIH to improve the quantity and quality of life.
Moderator
Michael Salgaller, PhD
Supervisory Specialist, National Cancer Institute Tech Transfer Center
National Institutes of Health (NIH)
Speakers
Mark Rohrbaugh, PhD
Special Advisor for NIH Technology Transfer
National Institutes of Health (NIH)
Margaret Anderson, MA
Managing Director
Deloitte Consulting LLP
Jeffery Alexander, PhD
Director, Innovation Policy
RTI International
Melissa Bonner, PhD
Chief Scientific Officer
Nvelop Therapeutics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS